Literature DB >> 13052820

The inactivation of complement and its components by plasmin.

L PILLEMER, O D RATNOFF, L BLUM, I H LEPOW.   

Abstract

Human complement is inactivated by plasmin, the proteolytic enzyme of plasma or serum active at or near neutrality. The addition of streptokinase to human serum, which converts plasminogen to plasmin, also causes the inactivation of complement components C'2 and C'4 and varying amounts of C'1. C'3 is the most resistant to inactivation by plasmin. Chloroform-activated human plasmin and bovine plasmin also destroy these components of complement, but are less effective than the streptokinase-activated enzyme. The inactivation of complement by the addition of streptokinase to human serum is inhibited by high hydrogen ion concentrations, low temperature, and elevated ionic strength. The inactivation of the components of complement in various fractions of serum is influenced by the available plasminogen and the content of plasmin inhibitors in these fractions. Certain similarities are pointed out between the components of complement and the factors in the plasmin system and between the inactivation of the components of complement by antigen-antibody reactions, by specific agents, and by plasmin. The possible significance of these relationships in immune hemolysis and complement fixation, and the possible role of the plasmin system in the instability of complement and the development of anticomplementary properties in serum are discussed.

Entities:  

Keywords:  COMPLEMENT; FIBRINOLYSIN

Mesh:

Substances:

Year:  1953        PMID: 13052820      PMCID: PMC2136289          DOI: 10.1084/jem.97.4.573

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  On the presence of a proteolytic enzyme in the normal serum of the ox.

Authors:  S G Hedin
Journal:  J Physiol       Date:  1903-11-02       Impact factor: 5.182

2.  Protease activation in immune reactions.

Authors:  W B GEIGER
Journal:  J Immunol       Date:  1952-01       Impact factor: 5.422

3.  Thrombin formation; effects of lysin (fibrinolysin, plasmin) on prothrombin, Ac-globulin and tissue thromboplastin.

Authors:  J H LEWIS; A C HOWE; J H FERGUSON
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

4.  Variations in proteolytic activity of serum of animals including man.

Authors:  E E CLIFFTON; G R DOWNIE
Journal:  Proc Soc Exp Biol Med       Date:  1950-04

5.  Prothrombin and Fibrinolysin.

Authors:  W H Seegers; E C Loomis
Journal:  Science       Date:  1946-11-15       Impact factor: 47.728

6.  Observations on the release of serum fibrinolysin by specific antigen, peptone, and certain polysaccharides.

Authors:  G UNGAR; S H MIST
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

7.  Studies on a proteolytic enzyme in human plasma. VIII. The effect of calcium and strontium ions on the activation of the plasma proteolytic enzyme.

Authors:  O D RATNOFF
Journal:  J Exp Med       Date:  1952-05       Impact factor: 14.307

8.  Studies on a proteolytic enzyme in human plasma; the probable identity of the enzymes activated by chloroform and by filtrates of cultures of beta hemolytic streptococci.

Authors:  O D RATNOFF
Journal:  J Exp Med       Date:  1948-03-01       Impact factor: 14.307

9.  A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS.

Authors:  O G Bier; G Leyton; M M Mayer; M Heidelberger
Journal:  J Exp Med       Date:  1945-05-01       Impact factor: 14.307

10.  THE ACTIVATING EFFECT OF MAGNESIUM AND OTHER CATIONS ON THE HEMOLYTIC FUNCTION OF COMPLEMENT.

Authors:  M M Mayer; A G Osler; O G Bier; M Heidelberger
Journal:  J Exp Med       Date:  1946-11-30       Impact factor: 14.307

View more
  39 in total

1.  Specific and nonspecific channels leading to proteolysis in antibody preparations.

Authors:  J Maillard; C Favreau
Journal:  Br J Exp Pathol       Date:  1975-04

2.  [Methodological and clinical studies on the properdin system. III. Studies on the behavior of 4 complement components after major gynecological operations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

3.  The growth and death of wound bacteria in serum, exudate and slough.

Authors:  L COLEBROOK; E J LOWBURY; L HURST
Journal:  J Hyg (Lond)       Date:  1960-12

4.  Studies on the activation of a serum esterase with ether and its relationship to C'l-esterase.

Authors:  V H DONALDSON
Journal:  J Clin Invest       Date:  1961-04       Impact factor: 14.808

5.  Action of phospholipids on the cytotoxic effect of rabbit antibodies against Ehrilich ascites tumour cells.

Authors:  I GINSBURG
Journal:  Br J Exp Pathol       Date:  1960-12

6.  The differentiation of the chloroform, peptone and antigen-antibody inducible esterase activities of human serum from plasmin.

Authors:  K F AUSTEN
Journal:  Immunology       Date:  1960-04       Impact factor: 7.397

7.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

8.  [Complement factors and properdin in a healthy infant during the first year of life].

Authors:  F KOCH; H E SCHULTZE; G SCHWICK
Journal:  Klin Wochenschr       Date:  1958-01-01

9.  The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients.

Authors:  W S TILLETT; A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

10.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.